2-es típusú cukorbetegség: vizsgálatok itt: Egyesült Királyság
62 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisNot yet taking people in Egyesült KirályságA Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
- Where
- Blackpool, Corby, Lancashire, London, Penzance, Romsey, West Kirby, Weston-super-Mare
- Életkor
- 18 év and over
- People
- 2115 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07881432 · EU 2026-526047-34-00 - 3. fázisTaking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Birmingham, Blackburn, Bournemouth, Bradford, Bristol, Bromborough, Chichester, Cosham, Darlington, Derby, Dundee, Falmouth, Guisborough, Ipswich, Kirkcaldy, Lancaster, Leeds, Lincoln, London, Manchester, Middlesbrough, Newcastle upon Tyne, Northallerton, Norwich, Southampton, Swansea, Trowbridge, Weymouth, York
- Életkor
- 18 év and over
- People
- 11 800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - 3. fázisNot yet taking people in Egyesült KirályságAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both
- Where
- Blackburn, Bushey, Chippenham, Liskeard, London, Nantwich, Rotherham, Sandbach, Swansea, Torquay, Truro
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931573 · EU 2026-525472-26-00 - 3. fázisNot yet taking people in Egyesült KirályságA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both
- Where
- Blackburn, London, Nantwich, Rotherham, Sandbach, Swansea, Truro, Wellingborough
- Életkor
- 18 év and over
- People
- 1060 worldwide
- Run by
- Novo Nordisk A/S
See details and how to joinNCT07931599 · EU 2026-525474-20-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Where
- Airdrie, Birmingham, Chippenham, Glasgow, Leicester, London, Newcastle upon Tyne, Soham, Swansea
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351045 · EU 2025-523104-71-00 - 3. fázisTaking peopleA Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Where
- Aberdeen, Antrim, Blackpool, Bristol, Dundee, Hounslow, Hull, Nuneaton, Plymouth, Taunton
- Életkor
- 18 év and over
- People
- 1600 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07351058 · EU 2025-523106-32-00 - No phaseBefejeződöttReal-World Study of Patients With Type 1 Diabetes Treated With Teplizumab as Part of Managed Access Programs (MAPs)
- Where
- Birmingham, London
- People
- 60 worldwide
- Run by
- Sanofi
See details and how to joinNCT07457580 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Where
- Airdrie, Chippenham, Hull, Llandough, Rotherham
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07776509 · EU 2025-523295-23-00 - 3. fázisTaking peopleA Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes
- Where
- Hull, Liverpool, London
- Életkor
- 10 év to 17 év
- People
- 170 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07668336 · EU 2025-524811-35-00 - 2. fázisTaking peopleA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Where
- Birmingham, Blackpool, Bristol, Bromborough, Newcastle, Newquay, Nuneaton, Poole, Rotherham, Torpoint
- Életkor
- 18 év to 75 év
- People
- 200 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT06897475 · EU 2024-520328-27-00 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Where
- Blackburn, Dundee, Guisborough, Nantwich, Rotherham, Thetford, Weston-super-Mare, Witney, Woodbridge, Yate
- Életkor
- 18 év and over
- People
- 2000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662109 · EU 2025-523941-81-00 - 3. fázisTaking peopleA Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Where
- Chippenham, Corby, Dunfermline, Hull, Northwood
- Életkor
- 18 év and over
- People
- 1500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07784270 - No phaseTaking peopleGLycaemic Outcomes With Whey Protein in ageING
- Where
- Birmingham
- Életkor
- 70 év to 90 év
- People
- 32
- Run by
- University of Birmingham
See details and how to joinNCT07285811 - 3. fázisTaking peopleA Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Where
- Aberdeen, Addlestone, Banbury, Bristol, Edinburgh, Hounslow, Penzance, Poole, Soham, Wansford, Yate
- Életkor
- 18 év and over
- People
- 1200 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662213 · EU 2025-523933-24-00 - No phaseTaking peopleA Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis
- Where
- Derby, London, Manchester
- Életkor
- 18 év and over
- People
- 84
- Run by
- Imperial College London
See details and how to joinNCT07422532 - 3. fázisTaking peopleKHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases
- Where
- London
- Életkor
- 18 év to 64 év
- People
- 220 worldwide
- Run by
- Khondrion BV
See details and how to joinNCT06451757 · EU 2025-522361-30-00 - 3. fázisTaking peopleA Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM
- Where
- Ashton-under-Lyne, Blackpool, Chesterfield, Corby, Ely, Glasgow, Hounslow, Leicester, Metropolitan Borough of Wirral, Nantwich, Poole, Rotherham, Stowmarket, Wansford, Witney, Yate
- Életkor
- 18 év and over
- People
- 4500 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07667803 - 3. fázisTaking peopleExtension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Where
- Birmingham
- Életkor
- 18 év to 99 év
- People
- 950 worldwide
- Run by
- Amgen
See details and how to joinNCT07684144 · EU 2025-524788-19-00 - No phaseTaking peopleSurveillance of Pancreatic Health After Diabetes Diagnosis
- Where
- Ashton-under-Lyne, Birmingham, Bournemouth, Brockham, Bromborough, Burton-on-Trent, Epsom, Kibworth Beauchamp, Kingswinford, Leek, Leicester, London, Maidstone, Manchester, Nottingham, Portsmouth, Rossendale, Ruislip, Sandbach, Southampton, Stratford-upon-Avon, Uttoxeter, Uxbridge, Walsall, Warlingham, Weymouth
- Életkor
- 50 év to 84 év
- People
- 5000
- Run by
- University Hospital Southampton NHS Foundation Trust
See details and how to joinNCT06803771 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Edinburgh, London
- Életkor
- 18 év to 99 év
- People
- 24 000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - 3. fázisTaking peopleA Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- Where
- Blackpool, Bradford on Avon, Lancashire, Lancaster, Londonderry, Manchester, Peterborough, Romsey, Torpoint
- Életkor
- 18 év and over
- People
- 1980 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07321886 · EU 2025-523657-34-00 - No phaseTaking peopleBenefits of Retained Insulin for Good Health
- Where
- Bath, Bristol, Exeter, Truro
- Életkor
- 18 év and over
- People
- 700
- Run by
- Royal Devon and Exeter NHS Foundation Trust
See details and how to joinNCT07828626 - 3. fázisNot yet taking people in Egyesült KirályságA Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- Where
- Cardiff, Edgbaston, Glasgow, London, Manchester, Stoke-on-Trent, Warrington
- Életkor
- 18 év and over
- People
- 1560 worldwide
- Run by
- Ascletis Pharma (China) Co., Limited
See details and how to joinNCT07743450 - 4. fázisTaking peopleA Study of Tirzepatide (LY3298176) Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes (SURMOUNT-REAL UK)
- Where
- Altrincham, Ashton-under-Lyne, Bolton, Bury, Cheshire, Great Lever, Hyde SK14, Manchester, Oldham, Rochdale, Sale, Salford, Stockport, Swinton, Wigen
- Életkor
- 18 év and over
- People
- 3000
- Run by
- Eli Lilly and Company
See details and how to joinNCT07247084 - 3. fázisTaking peopleA Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
- Where
- Blackpool, Glasgow, Hull, Penzance, Sandbach, Thetford, Whitney
- Életkor
- 18 év and over
- People
- 900 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07662135 · EU 2025-523940-12-00